Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Belgium

Galapagos Continues Alliances With Top Pharma

January 2010 | Industry Trend Analysis

Announcing its second major deal in six months, Belgian biotech company Galapagos has entered a research agreement with multinational drug company Roche - a transaction that could earn the development stage company up to US$573mn.

To read the full article, please choose one of the following options:

Subcribers please log in

Western Europe InsightWestern Europe Channels Western Europe Countries